2-(4-Chloro-5-(3-chlorophenyl)-1H-imidazol-1-yl)-5-(methylsulfonyl)pyridine

Catalog No. :
ACAEWQ795
CAS No. :
1425635-95-5
Molecular Formula :
C15H11Cl2N3O2S
Molecular Weight :
368.24

IUPAC Name:2-(4-chloro-5-(3-chlorophenyl)-1H-imidazol-1-yl)-5-(methylsulfonyl)pyridine

2-(4-Chloro-5-(3-chlorophenyl)-1H-imidazol-1-yl)-5-(methylsulfonyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Chloro-5-(3-chlorophenyl)-1H-imidazol-1-yl)-5-(methylsulfonyl)pyridine
IUPAC Name2-(4-chloro-5-(3-chlorophenyl)-1H-imidazol-1-yl)-5-(methylsulfonyl)pyridine
Molecular FormulaC15H11Cl2N3O2S
Molecular Weight368.24
SMILESO=S(C1=CN=C(N2C(C3=CC=CC(Cl)=C3)=C(Cl)N=C2)C=C1)(C)=O
InChI KeyNYQQVCWYMNKOMG-UHFFFAOYSA-N
Synonym2-(4-chloro-5-(3-chlorophenyl)-1H-imidazol-1-yl)-5-(methylsulfonyl)pyridine;Pyridine, 2-[4-chloro-5-(3-chlorophenyl)-1H-imidazol-1-yl]-5-(methylsulfonyl)-
CAS No.1425635-95-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAEWQ795 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNSOE016 route compound structure diagram
    ACNSOE01663503-60-6 In Stock
  4. Then
  5. ACAEWQ795 route product structure diagram
    ACAEWQ7951425635-95-5
Inquiry

2. ACAEWQ795 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZHPB257 route compound structure diagram
    ACZHPB25720277-69-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEWQ795 route product structure diagram
    ACAEWQ7951425635-95-5
Inquiry

Comments (0)